Cost-effectiveness in hepatitis B

被引：4
|
作者：
Weitzman, G [1 ]
Jacobson, I [1 ]
机构：
[1] Cornell Univ, Weil Med Coll, New York, NY 10021 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2005年 / 143卷 / 10期
关键词：
D O I：
10.7326/0003-4819-143-10-200511150-00021
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：757 / 758
页数：2
相关论文
共 50 条
  • [41] THE COST-EFFECTIVENESS OF HEPATITIS B AND C TESTING IN EMERGENCY DEPARTMENTS IN THE UK
    Williams, Jack
    Vickerman, Peter
    Douthwaite, Sam
    Nebbia, Gaia
    Hunter, Laura
    Wong, Terry
    Ruf, Murad
    Miners, Alec
    [J]. GUT, 2019, 68 : A131 - A132
  • [42] A COST-EFFECTIVENESS ANALYSIS OF HEPATITIS-B VACCINE IN PREDIALYSIS PATIENTS
    ODDONE, EZ
    COWPER, PA
    HAMILTON, JD
    FEUSSNER, JR
    [J]. HEALTH SERVICES RESEARCH, 1993, 28 (01) : 97 - 121
  • [43] COST-EFFECTIVENESS OF ANTENATAL HEPATITIS-B SCREENING AND VACCINATION OF INFANTS
    THOMAS, IL
    [J]. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 1990, 30 (04): : 331 - 335
  • [44] EVALUATION OF COST-EFFECTIVENESS OF CHRONIC HEPATITIS B TREATMENTS: ENTECAVIR AND TELBIVUDINE
    Suh, J. K.
    Hay, J.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A72 - A72
  • [45] Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha
    Desai, HG
    [J]. NATIONAL MEDICAL JOURNAL OF INDIA, 2003, 16 (03): : 175 - 175
  • [46] Cost-Effectiveness of Tenofovir Alafenamide for Treatment of Chronic Hepatitis B in Canada
    Tian, Feng
    Houle, Sherilyn K. D.
    Alsabbagh, Mhd. Wasem
    Wong, William W. L.
    [J]. PHARMACOECONOMICS, 2020, 38 (02) : 181 - 192
  • [47] Cost-effectiveness of Augmenting Universal Hepatitis B Vaccination With Immunoglobin Treatment
    Chen, Solomon Chih-Cheng
    Toy, Mehlika
    Yeh, Jennifer M.
    Wang, Jung-Der
    Resch, Stephen
    [J]. PEDIATRICS, 2013, 131 (04) : E1135 - E1143
  • [48] COST-EFFECTIVENESS OF PRENATAL SCREENING AND IMMUNIZATION FOR HEPATITIS-B VIRUS
    AREVALO, JA
    WASHINGTON, AE
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 259 (03): : 365 - 369
  • [49] Cost-effectiveness Analysis of the National Perinatal Hepatitis B Prevention Program
    Barbosa, Carolina
    Smith, Emily A.
    Hoerger, Thomas J.
    Fenlon, Nancy
    Schillie, Sarah F.
    Bradley, Christina
    Murphy, Trudy V.
    [J]. PEDIATRICS, 2014, 133 (02) : 243 - 253
  • [50] Cost-Effectiveness of Tenofovir Alafenamide for Treatment of Chronic Hepatitis B in Canada
    Feng Tian
    Sherilyn K. D. Houle
    Mhd. Wasem Alsabbagh
    William W. L. Wong
    [J]. PharmacoEconomics, 2020, 38 : 181 - 192
12345